Advertisement
Research Article

Tobacco Company Efforts to Influence the Food and Drug Administration-Commissioned Institute of Medicine Report Clearing the Smoke: An Analysis of Documents Released through Litigation

  • Crystal E. Tan,

    Affiliation: Center for Tobacco Control Research and Education, Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America

    X
  • Thomas Kyriss,

    Affiliation: Schillerhoehe Hospital, Thoracic Surgery, Gerlingen, Germany

    X
  • Stanton A. Glantz mail

    glantz@medicine.ucsf.edu

    Affiliation: Center for Tobacco Control Research and Education, Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America

    X
  • Published: May 28, 2013
  • DOI: 10.1371/journal.pmed.1001450

Reader Comments (2)

Post a new comment on this article

No conflict of interest statements provided in IOM report

Posted by bertzpoet on 29 May 2013 at 15:10 GMT

In my review of the IOM report, published in Nicotine & Tobacco Research (2002), S191-S193, I remarked that none of the staff or technical writers provided a statement about conflict of interest. While I am sure that that the chair of the committee report, Professor Stuart Bondarant, conducted himself in a professional and objective manner, it should have been noted that he had served on the AMA Committee on Smoking and Health, participating in the 1964–1972 AMA collaboration with the tobacco industry to distribute nearly twenty-five million dollars of company money in AMA research grants.

No competing interests declared.